Back
Arcellx, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
18
ACLX
Arcellx, Inc.
Last Price:
$66.49
Seasonality Move:
4.76%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.34
Seasonality Move:
-34.19%
Sell
18
Arcellx, Inc. (ACLX)
is a Sell
Is Arcellx, Inc. a Buy, Sell or Hold?
-
The current Arcellx, Inc. [ACLX] share price is $65.51. The Score for ACLX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
ACLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACLX Stock Price Chart
What is Arcellx, Inc.'s stock price today?
-
The Arcellx, Inc. share price today is $65.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACLX is experiencing slight buying pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $71.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.47 | Sell |
| Relative Strength Index (14 RSI): | 34.92 | Sell |
| Chaikin Money Flow: | 436630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.88 - 80.96) | Sell |
| Bollinger Bands (100): | (69.92 - 86.06) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 1903413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.41 - 65.27) | Buy |
| Bollinger Bands (100): | (17 - 45.24) | Buy |
ACLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.25 | Sell |
| 20-day SMA: | 69.43 | Sell |
| 50-day SMA: | 80.23 | Sell |
| 200-day SMA: | 71.52 | Sell |
| 8-day EMA: | 66.39 | Sell |
| 20-day EMA: | 70.52 | Sell |
| 50-day EMA: | 75.81 | Sell |
| 200-day EMA: | 74.08 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.43 | Buy |
| 20-day SMA: | 52.92 | Buy |
| 50-day SMA: | 40.28 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 64 | Buy |
| 20-day EMA: | 55.88 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 31.26 | Buy |
Arcellx, Inc. Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.50 per share, and an increase next year of $0.73 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Arcellx, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||